Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons

Vaccine

Volumn 32, Issue 31, 2014, Pages 3883-3885

  Donahue, Kelly L ^a   Stupiansky, Nathan W ^a   Alexander, Andreia B ^a   Zimet, Gregory D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescence; Healthcare providers; Human papillomavirus; Vaccination; Vaccine acceptability

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CHILD; CHILD HEALTH CARE; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HUMAN; MALE; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PHYSICIAN; PRIORITY JOURNAL; SON; UNITED STATES; VACCINATION; ATTITUDE TO HEALTH; PAPILLOMAVIRUS INFECTIONS; PARENT; PATIENT ATTITUDE; PSYCHOLOGY;

ADOLESCENT; CHILD; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES; VACCINATION;

EID: 84902010551     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.035     Document Type: Article

References (20)

1. Giuliano A.R., Lu B., Nielson C.M., Flores R., Papenfuss M.R., Lee J.H., et al. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis 2008, 198:827-835.
2. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297(8):813-819.
3. Forhan S.E., Gottlieb S.L., Sternberg M.R., Xu F., Datta S.D., McQuillan G.M., et al. Prevalence of sexually transmitted infections among female adolescents aged 14-19 in the United States. Pediatrics 2009, 124(6):1505-1512.
4. Baandrup L., Blomberg M., Dehlendorff C., Sand C., Andersen K.K., Kjaer S.K. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis 2013, 40(2):130-135.
5. Giuliano A.R., Palefsky J.M., Goldstone S., Moreira Jr E.D., Penny M.E., Aranda C., et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011, 364(5):401-411.
6. Hariri S., Markowitz L.E., Dunne E.F., Unger E.R. Population impact of HPV vaccines: summary of early evidence. J Adolesc Health 2013, 53(6):679-682.
7. Centers for Disease Control and Prevention Quadrivalent human papillomavirus vaccine: Recommendations of the ACIP. MMWR Morb Mortal Wkly Rep 2007, 56 (Early Release):1-24.
8. Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011, 60(50):1705-1708.
9. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13-17 years - United States, 2012. MMWR Morb Mortal Wkly Rep 2013, 62(34):685-693.
10. Zimet G.D., Rosberger Z., Fisher W.A., Perez S., Stupiansky N.W. Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation. Prev Med 2013, 57:414-418.
11. Reiter P.L., McRee A.L., Pepper J.K., Gilkey M.B., Galbraith K.V., Brewer N.T. Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health 2013, 103:1419-1427.
12. Holman D.M., Benard V., Roland K.B., Watson M., Liddon N., Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatrics 2013, E1-E7.
13. Darden P.M., Thompson D.M., Roberts J.R., Hale J.J., Pope C., Naifeh M., et al. Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010. Pediatrics 2013, 131(4):645-651.
14. Gerend M.A., Shepherd M.A., Shepherd J.E. The multidimensional nature of perceived barriers: global versus practical barriers to HPV vaccination. Health Psychol 2013, 32(4):p361.
15. Stupiansky N.W., Alexander A.B., Zimet G.D. Human papillomavirus vaccine and men: what are the obstacles and challenges?. Current Opin Infect Dis 2012, 25(1):86-91.
16. Kester L.M., Zimet G.D., Fortenberry J.D., Kahn J.A., Shew M.L. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J 2013, 17(5):879-885.
17. Wong C.A., Taylor J.A., Wright J.A., Opel D.J., Katzenellenbogen R.A. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health 2013, 53(4):492-497.
18. Kempe A., Daley M.F., McCauley M.M., Crane L.A., Suh C.A., Kennedy A.M., et al. Prevalence of parental concerns about childhood vaccines: the experience of primary care physicians. Am J Prev Med 2011, 40(5):548-555.
19. Opel D.J., Heritage J., Taylor J.A., Mangione-Smith R., Salas H.S., DeVere V., et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics 2013, 132(6):1037-1046.
20. Stupiansky N.W., Zimet G.D., Cummings T., Fortenberry J.D., Shew M. Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J Adolesc Health 2012, 50(1):103-105.